Seeing the Good in the Bad: Actual Clinical Outcome of Thrombectomy Stroke Patients with Formally Unfavorable Outcome

Overview

Journal Neuroradiology

Specialties Neurology
Radiology

Date 2022 Mar 8

PMID 35257206

Authors

Friederike Blum

Charlotte Hager

Homan Taufik

Martin Wiesmann

Dimah Hasan

Arno Reich

Joao Pinho

Omid Nikoubashman

Affiliations

Soon will be listed here.

Abstract

Purpose: Clinical outcome of stroke patients is usually classified into favorable (modified Rankin scale (mRS) 0-2) and unfavorable (mRS 3-5) outcome according to the modified Rankin scale. We took a closer look at the clinical course of thrombectomy stroke patients with formal unfavorable outcome and assessed whether we could achieve our treatment goals and/or neurological improvement in these patients.

Methods: We studied 107 patients with occlusions in the terminal carotid artery or the M1 segment of the middle cerebral artery, in whom complete recanalization (eTICI 3) could be achieved, and who had an mRS of 3-5 at 90 days. We analyzed whether an individual treatment goal (i.e., preventing aphasia) and neurological improvement (NIHSS) could be achieved. In addition, we examined whether there was clinical improvement on the mRS.

Results: The treatment goal was achieved in 52% (53/103) and neurological improvement in 65% (67/103). mRS 90 days post-stroke was better than mRS upon admission in 36% (38/107) and better than or equal to mRS upon admission in 80% (86/107). Of the 93 patients with known pre-stroke mRS, 18% (17/93) already had an mRS ≥ 3, with 15 of these 17 patients having a worse mRS on admission than before. Of these 17 patients, 18% regained baseline, and 24% improved from admission.

Conclusion: Dichotomizing the mRS into favorable and unfavorable outcome does not do justice to the full spectrum of stroke. Patients with formal unfavorable outcome after mRS can improve neurologically, achieve treatment goals, and even regain their admission or pre-stroke mRS.

References

Banks J, Marotta C . Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007; 38(3):1091-6. DOI: 10.1161/01.STR.0000258355.23810.c6. View

Saver J, Goyal M, Bonafe A, Diener H, Levy E, Pereira V . Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015; 372(24):2285-95. DOI: 10.1056/NEJMoa1415061. View

Lees K, Bath P, Schellinger P, Kerr D, Fulton R, Hacke W . Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke. 2012; 43(4):1163-70. DOI: 10.1161/STROKEAHA.111.641423. View

Nguyen T, Abdalkader M, Nagel S, Qureshi M, Ribo M, Caparros F . Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke With Large-Vessel Occlusion. JAMA Neurol. 2021; 79(1):22-31. PMC: 8576630. DOI: 10.1001/jamaneurol.2021.4082. View

Kleine J, Wunderlich S, Zimmer C, Kaesmacher J . Time to redefine success? TICI 3 versus TICI 2b recanalization in middle cerebral artery occlusion treated with thrombectomy. J Neurointerv Surg. 2016; 9(2):117-121. DOI: 10.1136/neurintsurg-2015-012218. View

Berkhemer O, Fransen P, Beumer D, van den Berg L, Lingsma H, Yoo A . A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2014; 372(1):11-20. DOI: 10.1056/NEJMoa1411587. View

Nikoubashman O, Jungbluth M, Schurmann K, Muller M, Falkenburger B, Tauber S . Neurothrombectomy in acute ischaemic stroke: a prospective single-centre study and comparison with randomized controlled trials. Eur J Neurol. 2016; 23(4):807-16. DOI: 10.1111/ene.12944. View

Singh R, Dekeyzer S, Reich A, Kotelis D, Gombert A, Wiesmann M . Emergency Carotid Endarterectomy Instead of Carotid Artery Stenting Reduces Delayed Hemorrhage in Thrombectomy Stroke Patients. Clin Neuroradiol. 2020; 31(3):737-744. PMC: 8463364. DOI: 10.1007/s00062-020-00954-7. View

Karlinski M, Kobayashi A, Czlonkowska A, Mikulik R, Vaclavik D, Brozman M . Role of preexisting disability in patients treated with intravenous thrombolysis for ischemic stroke. Stroke. 2014; 45(3):770-5. DOI: 10.1161/STROKEAHA.113.003744. View

10.

Nogueira R, Jadhav A, Haussen D, Bonafe A, Budzik R, Bhuva P . Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2017; 378(1):11-21. DOI: 10.1056/NEJMoa1706442. View

11.

Lai S, Duncan P . Stroke recovery profile and the Modified Rankin assessment. Neuroepidemiology. 2001; 20(1):26-30. DOI: 10.1159/000054754. View

12.

Thomalla G, Fiebach J, Ostergaard L, Pedraza S, Thijs V, Nighoghossian N . A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke. 2013; 9(6):829-36. DOI: 10.1111/ijs.12011. View

13.

Goyal M, Menon B, van Zwam W, Dippel D, Mitchell P, Demchuk A . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016; 387(10029):1723-31. DOI: 10.1016/S0140-6736(16)00163-X. View

14.

Ma H, Campbell B, Parsons M, Churilov L, Levi C, Hsu C . Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke. N Engl J Med. 2019; 380(19):1795-1803. DOI: 10.1056/NEJMoa1813046. View

15.

Jorger M, Beer S, Kesselring J . Impact of neurorehabilitation on disability in patients with acutely and chronically disabling diseases of the nervous system measured by the Extended Barthel Index. Neurorehabil Neural Repair. 2001; 15(1):15-22. DOI: 10.1177/154596830101500103. View

16.

Kwon S, Hartzema A, Duncan P, Min-Lai S . Disability measures in stroke: relationship among the Barthel Index, the Functional Independence Measure, and the Modified Rankin Scale. Stroke. 2004; 35(4):918-23. DOI: 10.1161/01.STR.0000119385.56094.32. View

17.

Kidd D, Stewart G, Baldry J, Johnson J, Rossiter D, Petruckevitch A . The Functional Independence Measure: a comparative validity and reliability study. Disabil Rehabil. 1995; 17(1):10-4. DOI: 10.3109/09638289509166622. View

18.

Sulter G, Steen C, De Keyser J . Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke. 1999; 30(8):1538-41. DOI: 10.1161/01.str.30.8.1538. View

19.

Hong K, Saver J . Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale. Stroke. 2009; 40(12):3828-33. PMC: 2788070. DOI: 10.1161/STROKEAHA.109.561365. View

20.

Rebchuk A, ONeill Z, Szefer E, Hill M, Field T . Health Utility Weighting of the Modified Rankin Scale: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020; 3(4):e203767. PMC: 7191324. DOI: 10.1001/jamanetworkopen.2020.3767. View